HepatitisB: An in-vitro assay of three hepatitis B vaccines against a...

In pla: Parallel Line Assays

Description

5.1.4. FIVE-DOSE MULTIPLE ASSAYWITH COMPLETELY RANDOMIZED DESIGN

Usage

data("HepatitisB")

Details

From Ph.Eur.:

3 independent two-fold dilution series of 5 dilutions were prepared from each of the vaccines. After some additional steps in the assay procedure, absorbance's were measured. They are shown in Table 5.1.4.-I. The logarithms of the optical densities are known to have a linear relationship with the logarithms of the doses. The mean responses of the ln-transformed optical densities are listed in Table 5.1.4.-II. No unusual features are discovered in a graphical presentation of the data.

Source

The example can also be found at CombiStats - EDQM, Council of Europe (http://combistats.edqm.eu): http://combistats.edqm.eu/content/view/189/199/

References

Chapter 5.3. Statistical analysis. In EUROPEAN PHARMACOPOEIA version 8.0, 2014; 607-635.

Examples

data(HepatitisB); Data <- HepatitisB

cbbPalette <- c("#000000", "#009E73", "#e79f00", "#9ad0f3",
                "#0072B2", "#D55E00", "#CC79A7", "#F0E442")

Data <- readAssayTable(paste(system.file(package = "pla"),
                             "vignettes/PhEur/data/HepatitisB.txt",
                             sep = "/"), fun = log)
plaModel <- plaCRD(Data,
                   assayTitle =
            "PhEur: HepatitisB; Three hepatitis B vaccines against a standard")
plaModel
plots    <- plot(plaModel)

pla documentation built on May 2, 2019, 11:12 a.m.